{"cik":1709401,"taxonomy":"us-gaap","tag":"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount","label":"Lessee, Operating Lease, Liability, Undiscounted Excess Amount","description":"Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.","entityName":"RUBIUS THERAPEUTICS, INC.","units":{"USD":[{"end":"2019-03-31","val":9253000,"accn":"0001558370-19-005047","fy":2019,"fp":"Q1","form":"10-Q","filed":"2019-05-15","frame":"CY2019Q1I"},{"end":"2019-06-30","val":8708000,"accn":"0001558370-19-008018","fy":2019,"fp":"Q2","form":"10-Q","filed":"2019-08-13","frame":"CY2019Q2I"},{"end":"2019-09-30","val":15857000,"accn":"0001558370-19-010992","fy":2019,"fp":"Q3","form":"10-Q","filed":"2019-11-14","frame":"CY2019Q3I"},{"end":"2019-12-31","val":14942000,"accn":"0001558370-20-002475","fy":2019,"fp":"FY","form":"10-K","filed":"2020-03-12","frame":"CY2019Q4I"},{"end":"2020-12-31","val":11702000,"accn":"0001558370-21-001412","fy":2020,"fp":"FY","form":"10-K","filed":"2021-02-23","frame":"CY2020Q4I"},{"end":"2021-12-31","val":8815000,"accn":"0001558370-22-002057","fy":2021,"fp":"FY","form":"10-K","filed":"2022-02-25","frame":"CY2021Q4I"},{"end":"2022-12-31","val":0,"accn":"0001709401-23-000005","fy":2022,"fp":"FY","form":"10-K","filed":"2023-02-27","frame":"CY2022Q4I"}]}}